Oct 1
|
Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
|
Sep 30
|
Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
|
Sep 30
|
Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...
|
Aug 5
|
Teva Pharmaceutical Industries Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Aug 1
|
TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up
|
Jul 31
|
Teva Pharma, With A 67% Gain This Year, Flirts With A Breakout On Beat-And-Raise Report
|
Jul 29
|
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
|
Jul 29
|
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
|
Jul 25
|
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
|
Jul 2
|
Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
|
Jul 2
|
FTC investigates Teva over contested product patents
|
Jul 1
|
Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings
|
Jul 1
|
Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity
|
Jun 24
|
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
|
Jun 24
|
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
|
Jun 22
|
Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?
|
Jun 13
|
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
|
May 15
|
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
|
May 14
|
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
|
May 14
|
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
|